Search | TVST | ARVO Journals

Showing 1 – 20 of 122

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

SD-OCT Features and Macular Sensitivity in ABCA4 -related Stargardt disease (STGD1)

Yanzhao WANG; Folahan Adesola Ibukun; Elias Traboulsi; David G Birch; Janet S Sunness; Rupert Strauss; Isabelle S Audo; Michel Michaelides; SriniVas R Sadda; Hendrik P Scholl; Eberhart Zrenner; Michael S Ip; Artur V Cideciyan; Paul S Bernstein; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):975.

ARVO Annual Meeting Abstract June 2024

Longitudinal structure-function (S-F) relationship between short-wavelength autofluorescence (SW-FAF) and macular sensitivity (MS) in ABCA4 -associated Stargardt (STGD1) disease

Folahan Adesola Ibukun; Yanzhao Wang; Artur V Cideciyan; David G Birch; Janet S Sunness; Isabelle S Audo; Michel Michaelides; Elias Traboulsi; SriniVas R Sadda; Michael S Ip; Hendrik P Scholl; Rupert Strauss; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3350.

ARVO Annual Meeting Abstract June 2024

Spatial and anatomic parameters from SD-OCT and associations with best corrected visual acuity (BCVA) in ABCA4-associated Stargardt Disease (STGD1)

Xiangrong Kong; Yanzhao WANG; Folahan Adesola Ibukun; David G Birch; Elias Traboulsi; Janet S Sunness; Paul S Bernstein; Isabelle S Audo; Michel Michaelides; SriniVas R Sadda; Hendrik P Scholl; Eberhart Zrenner; Michael S Ip; Sheila K West; Artur V Cideciyan; Rupert Strauss

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2374.

ARVO Annual Meeting Abstract June 2024

Early-onset sub-RPE deposits in late-onset retinal degeneration (L-ORD) caused by the c.489C>G (p.S163R) founder variant in C1QTNF5

Artur V Cideciyan; Randa TH Li; Alejandro J Roman; Alexander Sumaroka; Chloe M Stanton; Malgorzata Swider; Alexandra V Garafalo; Elise Heon; Ajoy Vincent; Alan F Wright; Roly Megaw; Tomas S Aleman; Andrew C Browning; Baljean Dhillon

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1385.

ARVO Annual Meeting Abstract June 2024

Treatment Potential of RPGRIP1 -associated Inherited Retinal Degenerations

Emma Bedoukian; Jean Bennett; Katherine E. Uyhazi; Albert Maguire; Erin O'Neil; Emily Krauss; Alejandro J Roman; Alexander Sumaroka; Malgorzata Swider; Drew Scoles; Alexandra V Garafalo; Artur V Cideciyan; Tomas S Aleman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2209.

ARVO Annual Meeting Abstract June 2024

AAV8- hLCA5 Subretinal Delivery to the Macula in LCA5 -associated Leber Congenital Amaurosis ( LCA5 -LCA): Preliminary Safety and Efficacy Results of an Ongoing Phase I/II Gene Therapy Trial

Tomas S Aleman; Artur V Cideciyan; Mariejel L Weber; Arlene Santos; Katherine E. Uyhazi; Kelsey Parchinski; William Chung; Paris Margaritis; junwei sun; Drew Scoles; Alexandra V Garafalo; Ashwath Jayagopal; Benjamin R Yerxa; Sarah Tuller; Albert Maguire; Jean Bennett

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3288.

ARVO Annual Meeting Abstract June 2024

A canine model for ABCA4 Stargardt disease: in-vivo phenotypic characterization and natural disease history

Valerie L. Dufour; Artur V Cideciyan; Jennifer Kwork; Alexa Gray; Yu Sato; Kyle Quigley; William A Beltran; Gustavo D Aguirre

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4739.

ARVO Annual Meeting Abstract June 2024

Defining the late-onset retinal degeneration (L-ORD) phenotype: novel findings in clinical characterisation

Randa Li; Chloe M Stanton; Roly Megaw; Alan F Wright; Andrew C Browning; Artur V Cideciyan; Samuel G Jacobson; Baljean Dhillon

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5396.

ARVO Annual Meeting Abstract June 2024

Development of OPGx-BEST1 AAV gene therapy for the treatment of bestrophinopathies

Mayur Choudhary; Alexa Gray; Yu Sato; Jennifer Caroline Kwok; Vik Arora; Benjamin R Yerxa; Artur V Cideciyan; Gustavo D Aguirre; William A Beltran; Ashwath Jayagopal

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5335.

Retina December 2023

Treatment Strategy With Gene Editing for Late-Onset Retinal Degeneration Caused by a Founder Variant in C1QTNF5

PDF

Randa T. H. Li; Alejandro J. Roman; Alexander Sumaroka; Chloe M. Stanton; Malgorzata Swider; Alexandra V. Garafalo; Elise Heon; Ajoy Vincent; Alan F. Wright; Roly Megaw; Tomas S. Aleman; Andrew C. Browning; Baljean Dhillon; Artur V. Cideciyan
TAGS: gene editing, photoreceptors, retina, retinal degeneration, tissue degeneration, diagnostic imaging, retinal cone, fovea centralis, natural history, eye
Invest. Ophthalmol. Vis. Sci.. 2023; 64(15):33. https://doi.org/10.1167/iovs.64.15.33

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Six-month safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D (LCA1)

Christine Nichols Kay; Paul Yang; Artur V Cideciyan; Allen Ho; Andreas K Lauer; Shannon E Boye; Sanford L Boye; Alejandro J Roman; Vivian Wu; Alexandra V Garafalo; Alexander Sumaroka; Laura P Pardon; Dan Yoon; Kenji P Fujita; Samuel Jacobson

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1914.

ARVO Annual Meeting Abstract June 2023

Long durability of foveal cone vision improvement after single injections of sepofarsen confirmed in a second CEP290 -LCA eye

Artur V Cideciyan; Samuel Jacobson; Allen Ho; Malgorzata Swider; Alexander Sumaroka; Alejandro J Roman; Alexandra V Garafalo; Vivian Wu; Michael Schwartz; Aniz Girach

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3833.

Retina January 2023

Color Vision in Blue Cone Monochromacy: Outcome Measures for a Clinical Trial

PDF

Abraham A. Mascio; Alejandro J. Roman; Artur V. Cideciyan; Rebecca Sheplock; Vivian Wu; Alexandra V. Garafalo; Alexander Sumaroka; Sydney Pirkle; Susanne Kohl; Bernd Wissinger; Samuel G. Jacobson; John L. Barbur
TAGS: color, color perception, color vision, outcome measures, retinal cone, eye, c statistic
Trans. Vis. Sci. Tech.. 2023; 12(1):25. https://doi.org/10.1167/tvst.12.1.25

Includes: Supplemental Content

Retina December 2022

Photoreceptor Function and Structure in Autosomal Dominant Vitelliform Macular Dystrophy Caused by BEST1 Mutations

PDF

Artur V. Cideciyan; Samuel G. Jacobson; Malgorzata Swider; Alexander Sumaroka; Rebecca Sheplock; Arun K. Krishnan; Alexandra V. Garafalo; Karina E. Guziewicz; Gustavo D. Aguirre; William A. Beltran; Elise Heon
TAGS: best1 gene, eye, mutation, photoreceptors, retina, retinal cone, rod photoreceptors, vitelliform dystrophy, fovea centralis, vision
Invest. Ophthalmol. Vis. Sci.. 2022; 63(13):12. https://doi.org/10.1167/iovs.63.13.12

ARVO Annual Meeting Abstract June 2022

Long-term follow up of gene therapy for NPHP5 -LCA in a canine model shows restoration of photoreceptor function and vision for > 5 years

William A Beltran; Artur V Cideciyan; Ana Ripolles-Garcia; Valerie L Dufour; Yu Sato; Alexa Gray; Malgorzata Swider; Sanford L Boye; William W Hauswirth; Samuel G. Jacobson; Gustavo D Aguirre

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):454.

ARVO Annual Meeting Abstract June 2022

Long-term safety and efficacy of sepofarsen in a Ph1b/2 INSIGHT extension trial in CEP290 -associated Leber congenital amaurosis (LCA10)

Stephen R Russell; Arlene V Drack; Artur V Cideciyan; Samuel G. Jacobson; Bart P Leroy; Caroline Van Cauwenbergh; Michael Schwartz; Aniz Girach

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):453.

Articles September 2021

Macular Rod Function in Retinitis Pigmentosa Measured With Scotopic Microperimetry

PDF

Arun K. Krishnan; Alejandro J. Roman; Malgorzata Swider; Samuel G. Jacobson; Artur V. Cideciyan
TAGS: retinitis pigmentosa, rod photoreceptors, dynamic range
Trans. Vis. Sci. Tech.. 2021; 10(11):3. https://doi.org/10.1167/tvst.10.11.3

ARVO Annual Meeting Abstract June 2021

Macular rod function in retinitis pigmentosa (RP): Comparison of scotopic microperimeter to modified Humphrey field analyzer

Arun kumar Krishnan; Alejandro Roman; Malgorzata Swider; Samuel G Jacobson; Artur V Cideciyan

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3545.

ARVO Annual Meeting Abstract June 2021

Safety and efficacy of sepofarsen in the second treated eye in a Ph1b/2 extension trial in Leber Congenital Amaurosis type 10 (LCA10)

Stephen R Russell; Arlene V Drack; Artur V Cideciyan; Samuel G Jacobson; Bart Leroy; Allen Ho; Caroline Van Cauwenbergh; Arun kumar Krishnan; Wilhelmina R. den Hollender; Adriana Hollestein-Havelaar; Mike Schwartz; Aniz Girach

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3317.

ARVO Annual Meeting Abstract June 2021

Changes of Fixation Stability and Fixation Location over 24 Months in Stargardt Disease: the ProgStar Study

Etienne Schönbach; Rupert Strauss; Marco Cattaneo; David G Birch; Artur V Cideciyan; Janet S Sunness; Kaoru Fujinami; Eberhart Zrenner; Srinivas R Sadda; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2167.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

SD-OCT Features and Macular Sensitivity in ABCA4 -related Stargardt disease (STGD1)

Longitudinal structure-function (S-F) relationship between short-wavelength autofluorescence (SW-FAF) and macular sensitivity (MS) in ABCA4 -associated Stargardt (STGD1) disease

Spatial and anatomic parameters from SD-OCT and associations with best corrected visual acuity (BCVA) in ABCA4-associated Stargardt Disease (STGD1)

Early-onset sub-RPE deposits in late-onset retinal degeneration (L-ORD) caused by the c.489C>G (p.S163R) founder variant in C1QTNF5

Treatment Potential of RPGRIP1 -associated Inherited Retinal Degenerations

AAV8- hLCA5 Subretinal Delivery to the Macula in LCA5 -associated Leber Congenital Amaurosis ( LCA5 -LCA): Preliminary Safety and Efficacy Results of an Ongoing Phase I/II Gene Therapy Trial

A canine model for ABCA4 Stargardt disease: in-vivo phenotypic characterization and natural disease history

Defining the late-onset retinal degeneration (L-ORD) phenotype: novel findings in clinical characterisation

Development of OPGx-BEST1 AAV gene therapy for the treatment of bestrophinopathies

Treatment Strategy With Gene Editing for Late-Onset Retinal Degeneration Caused by a Founder Variant in C1QTNF5

Six-month safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D (LCA1)

Long durability of foveal cone vision improvement after single injections of sepofarsen confirmed in a second CEP290 -LCA eye

Color Vision in Blue Cone Monochromacy: Outcome Measures for a Clinical Trial

Photoreceptor Function and Structure in Autosomal Dominant Vitelliform Macular Dystrophy Caused by BEST1 Mutations

Long-term follow up of gene therapy for NPHP5 -LCA in a canine model shows restoration of photoreceptor function and vision for > 5 years

Long-term safety and efficacy of sepofarsen in a Ph1b/2 INSIGHT extension trial in CEP290 -associated Leber congenital amaurosis (LCA10)

Macular Rod Function in Retinitis Pigmentosa Measured With Scotopic Microperimetry

Macular rod function in retinitis pigmentosa (RP): Comparison of scotopic microperimeter to modified Humphrey field analyzer

Safety and efficacy of sepofarsen in the second treated eye in a Ph1b/2 extension trial in Leber Congenital Amaurosis type 10 (LCA10)

Changes of Fixation Stability and Fixation Location over 24 Months in Stargardt Disease: the ProgStar Study

To View More...

You must be signed into an individual account to use this feature.